LDL and triglycerides

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Tirzepatide or semaglutide use

downin humans1

1 study
  1. Tirzepatide or semaglutide use is associated with LDL and triglycerides in humans.

    “Significant improvements were observed in A1c, BMI, systolic and diastolic BP, LDL, and triglycerides (p < .001).”

    HumansRural-dwelling adults with prediabetes and overweight or obesity3–24 monthsn = 40

    A Retrospective Chart Review of Tirzepatide and Semaglutide Use in Prediabetes Management and Cardiometabolic Outcomes in a Rural Primary Care Setting

    Journal of doctoral nursing practice15 Oct 2026

More on Tirzepatide or semaglutide use

Latest

Nov 2025: 3Dec 2025: 6Jan 2026: 2Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 3Sep 2026: 3Oct 2026: 222 in 12 months